Making use of technological advancements to bring in higher efficiency, and as a testimony of the Company’s commitment to the India market, Çelebi Delhi Cargo Terminal Management has announced that it has been accredited with IATA CEIV Pharma certification for its cargo and warehouse operations. Given the current scenario, the air cargo industry is calling for higher standards when transporting temperature sensitive pharmaceuticals. To cope with the growing expectation for standardization, the certification ensures international and national compliance to safeguard product integrity to its destination.

From the onset of the COVID-19 pandemic, Çelebi has been working dedicatedly on preparing proficient handling scenarios for the import and export of various types of vaccines, pharma, medical aid, and oxygen containers in a safe and efficient way. Vaccines, in general, must be handled in line with international regulatory requirements at a controlled temperature and without delay to ensure the quality of the product. For this, Çelebi has been investing in restructuring and redesigning new material handling systems that are intelligent and advanced technology driven. With this CEIV certification Celebi will be capable of building additional certified temperature control rooms as required.

Mr. Kamesh Peri, CEO, Çelebi Delhi Cargo Terminal Management said, “This is a prestigious certification to have, especially in present times with the highest standards expected in handling temperature-sensitive pharmaceuticals. We have achieved it after a thorough audit process performed by IATA who assessed and found our quality systems, infrastructure, procedures, and policies to be in absolute compliance. This was made possible by our committed team and I am very proud of their tireless & brilliant efforts.”